Output Biosciences is the world’s first preventative therapeutics company that extends human healthspan by combating chronic disease.
Adi Mashiach, MD, is a co-founder of Output Biosciences. Adi is a serial entrepreneur, former OBGYN and computational biology researcher. Adi was previously founder CEO of Nyxoah (NASDAQ:NYXH, $600M market cap) that makes one of the most effective Sleep Apnea therapy on the market, and Innovea (acquired), a medical computer vision startup. Adi's computational biology research allowed to predict response to cancer therapy just from cell images. Adi is an inventor of over 70 granted US patents.
Mirella Mashiach is a co-founder of Output Biosciences. Mirella is a big pharma executive and biotech investor. Mirella is the former Managing Director of the $200M corporate venture biotech fund at Teva Pharmaceuticals and its VP of BD and Strategy. Mirella was an attorney in Dentons, where she focused on corporate, commercial and intellectual property deals in life sciences and medical devices.